Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

11.34USD
18 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.34
Open
$11.11
Day's High
$11.47
Day's Low
$10.52
Volume
33,786
Avg. Vol
43,491
52-wk High
$17.39
52-wk Low
$7.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.31 -0.208
Jun '18 2.03 -0.194
Mar '18 1.46 -0.202
FY 2017 Dec '17 16.42 0.073
Sep '17 1.07 -0.154
Jun '17 0.75 -0.216
Mar '17 2.01 -0.166
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 2.03 2.03 2.03 --
Quarter Ending Jun-19 1 2.03 2.03 2.03 --
Year Ending Dec-19 4 38.87 79.62 0.00 10.02
Earnings (per share)
Quarter Ending Mar-19 1 -0.19 -0.19 -0.19 --
Quarter Ending Jun-19 1 -0.20 -0.20 -0.20 --
Year Ending Dec-19 4 -0.47 0.04 -0.98 -1.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 113.23 49.51 6.28
Price to Book (MRQ) 5.17 10.16 5.27
Price to Tangible Book (MRQ) 5.17 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 18.18 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.23 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -87.77 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -190.05 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -263.41 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 21.60 3.43 3.08
LT Debt to Equity (MRQ) 0.32 18.73 11.38
Total Debt to Equity (MRQ) 0.32 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -594.80 -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -601.68 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -645.62 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -645.62 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,281 7,650,695 844,239,566
Net Income/Employee (TTM) -544,130 652,572 100,064,145
Receivable Turnover (TTM) 8.62 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.05 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -32.55 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -33.72 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -40.61 39.04 --
EPS (TTM) % -137.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AC Immune SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 19.53 15.41 81 99
13 Week 31.08 24.70 81 95
26 Week 11.71 3.21 64 98
52 Week -29.98 -40.65 29 72
YTD -13.25 -23.82 31 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.66%
# of Holders: 41
Total Shares Held: 20,976,427
3 Mo. Net Change: 819,731
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.